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We aimed to assess health-impacts of short-term exposure to the air pollutants including PM10, SO2, and NO2 in
Shiraz, Iran in a two-part study from 2008 to 2010. In part I, local relative risks (RRs) and baseline incidences (BIs)
were calculate using generalized additive models. In part II, we estimated the number of excess hospitalizations
(NEHs) due to cardiovascular diseases (CDs), respiratory diseases (RDs), respiratory diseases in elderly group
(RDsE—people older than 65 years old), and chronic obstructive pulmonary diseases (COPDs) as a result of
exposure to air pollutants using AirQ model, which is proposed approach for air pollution health impact assessment
by World Health Organization. In part I, exposure to increase in daily mean concentration of PM10 was associated
with hospitalizations due to RDs with a RR of 1.0049 [95% confidence interval (CI), 1.0004 to 1.0110]. In addition,
exposure to increase in daily mean concentration of SO2 and NO2 were associated with hospitalizations due to
RDsE and COPDs with RRs of 1.0540 [95% CI, 1.0050 to 1.1200], 1.0950 [95% CI, 1.0700 to 1.1100], 1.0280 [95% CI,
1.0110 to 1.0450] and 1.0360 [95% CI, 1.0210 to 1.0510] per 10 μg/m3 rise of these pollutants, respectively. In part II,
the maximum NEHs due to CDs because of exposure to PM10 were in 2009—1489 excess cases (ECs). The
maximum NEHs due to RDs because of exposure to PM10 were in 2009—1163 ECs. Meanwhile, the maximum NEHs
due to RDsE and COPDs because of exposure to SO2 were in 2008, which are 520 and 900 ECs, respectively. In
conclusion, elevated morbidity risks were found from acute exposure to air pollutants.
Keywords: Air Pollution, AirQ, Cardiovascular Diseases, COPD, Excess Hospitalizations, Health Impact Assessment,
Iran, Particulate Matter, Respiratory, ShirazIntroduction
Cardiovascular and respiratory diseases, such as chronic
obstructive pulmonary diseases (COPDs), are one of the
leading causes of mortality and disease burden (e.g.,
disability-adjusted life years (DALYs)), globally [1,2]. They
are increasingly worldwide most prevalent health problems
and albeit variety of risk factors have been recognized and
introduced as the most common causes of commence or
exacerbation, the role of air pollution is irrefutable [3-5]. In
fact, many time-series and case-crossover studies [6-14]
have demonstrated the contribution of air pollutants in
hospitalizations, morbidities, and mortalities (i.e., years of* Correspondence: amini_h@razi.tums.ac.ir; yunesian@tums.ac.ir
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distribution, and reproduction in any mediumlife lost—YLL) due to cardiopulmonary diseases, which
have been approved by large prospective cohort studies
[15,16]. With these as backdrop, the importance of health
impact assessment (HIA) of air pollutants in local-scales is
obvious to quantify these health impacts, and to develop
successful and effective management schemes to reduce
YLL and years of life disabled (YLD)—DALYs.
Shiraz—the capital city of Fars province in Southwest of
Iran—is one of the largest cities in Iran that is in counter
with high amounts of air pollution since last decades as a
result of population growth, urbanization, and hence, in-
creased traffic-related air pollution. Besides, the high in-
fluxes of air pollutants in last decade through dust storms,
well known as Middle Eastern Dust (MED) events, have
deteriorated the welkin dramatically. Here, the authors
aimed to assess the health impacts of short-term expos-
ure to air pollutants in Shiraz city in a two-part study
from 2008 to 2010.entral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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This study was conducted in two parts in Shiraz city of
Iran—parts I and II. In part I, local relative risks (RRs)
and baseline incidences (BIs) were calculate. In part II,
calculation and comparison of number of the excess
cardiovascular and respiratory hospitalizations because
of exposure to air pollutants were done first by using
existed default relative risk (RR) and baseline incidence
(BI) of the air quality health impact assessment software
AirQ 2.2.3, which is proposed approach by World
Health Organization (WHO) for HIA [17]; and second
by calculated RR and BI of part I or by applying a com-
bination of these RRs and BIs in AirQ model.
Part I: calculation of local RRs and BIs
In this part, associations of exposure to air pollutants
and hospitalizations due to cardiovascular and respira-
tory causes were examined in Shiraz city as the target
population from 2008 to 2010.
Study area and demographic parameters
Shiraz is the capital city of Fars Province in Southwest of
Iran (Figure 1). It is located in the latitude of 29°36′ N
and the longitude of 52°32′ E with average elevation of
1500 m above sea level. According to the latest census
report by Statistical Centre of Iran (SCI) in 2005, theFigure 1 The study area of Shiraz, Iran and location of the air qualitypopulation is 1,2 million people, which this number has
been estimated to increase to 1,3 million people in 2010.
The population of people older than 65 years old is
about 85913. Meanwhile, Shiraz has a population growth
rate of 1.3% based on the estimates of SCI [18].Air pollution data
At the time of conducting this study there were two
fixed air pollution monitors belonged to the Fars's De-
partment of Environment (F-DOE) (Figure 1). Hourly air
pollution data including particulate matter with aero-
dynamic diameter less than 10 μm (PM10), sulfur dioxide
(SO2), and nitrogen dioxide (NO2) obtained from F-
DOE. Thereafter, 24-hour means were calculated for
each pollutant.Morbidity cases and classification
The numbers of daily hospitalizations due to cardiovascular
and respiratory causes were obtained fromMedical Records
Departments (MRD) of Shiraz hospitals. The MRDs
of Shiraz hospitals provided morbidity cases in line with
taxonomy of the International Classification of Diseases
(ICD-10). According to the ICD-10, I00 to I99 and J00 to
J99 codes have been defined for cardiovascular and respira-
tory diseases, respectively [19].monitoring stations.
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Correlation evaluation and RR calculation were done by
applying Poisson regression with logarithmic link in gen-
eralized additive models (GAM). The GAM is expressed
as the following equation [12]:
log E Yð Þ½  ¼ β0 þ β1  pollutant þ Si Xið Þ þ ⋅⋅⋅ þ Sp Xp
 
ð1Þ
Where Y denotes the number of daily hospitalizations;
E(Y) denotes the number of expected cases; Xi, i = 1,…,p
which can be temperature, relative humidity, time, etc.;
and Si, i = 1,…,p denotes smooth functions.
In order to analyze the data, first, quality of them were
checked for missing data and errors using SPSS and
Microsoft Office Excel, and resolved as possible. In this
part of the study, the effects of meteorology variables
including temperature and relative humidity; day of the
week including working days, holidays, and days after hol-
idays; and time were entered to the model as confounding
factors and their effects were removed on number of hos-
pitalizations using smooth function to calculate net effect
of pollutant on the number of hospitalizations. In order to
adjust the effect of those predictor variables in which
affect response variable with lag of several days, smooth
function was applied on auto regressive values. Finally,
GAM models were fitted on the data using "mgcv" pack-
age in R statistical software [20,21].
Part II: health impact assessment of air pollution
The main aim of this part of the study was HIA of air pol-
lution on the target population using AirQ 2.2.3 software.
This software has been developed to estimate the health
impacts of exposure to specific air pollutants on a resident
population in a certain area and period. In this software,
HIA of air pollutants is standing on calculation of attribut-
able proportion (AP) in which AP is fraction of health
consequences in a specific population that can be attri-
buted to a specific air pollutant exposure with this notion
that there is proven causative correlation between health
consequences and air pollutant exposure [22,23]. The AP
is calculated as the following equation [23]:
AP ¼ Σ RR cð Þ−1½   P cð Þf g
Σ RR cð Þ  P cð Þ½  ð2Þ
Where RR denotes the relative risk for a given health
endpoint, in category “c” of exposure, obtained from the
concentration–response functions derived from wide lit-
erature (i.e., current existent epidemiological studies) and
P(c) denotes the proportion of the population in category
“c” of exposure.
The rate attributable to the exposure can be calculated
as the following equation if the baseline frequency of thehealth endpoint is known in the population:
IE ¼ I  AP ð3Þ
Where IE denotes the rate of the health outcome attribut-
able to the exposure and I denotes the baseline frequency of
the health endpoint in the population.
Finally, the number of cases attributable to the expos-
ure can be estimated as the following equation knowing
the size of the population:
NE ¼ IEN ð4Þ
Where NE denotes the number of cases attributed to
the exposure and N denotes the size of the population
investigated.
In this research, air quality, health outcomes, and exposed
population data were entered to the software for the period
of 2008 to 2010. Moreover, estimation of the excess hospital-
izations due to cardiovascular diseases, respiratory diseases,
COPDs, and respiratory diseases in elderly group—people
older than 65 years-old—as a result of short-term exposure
to PM10, SO2, and NO2 were calculated using RR and BI of
WHO, RR and BI of part I, RR ofWHO and BI of part I, and
RR of part I and BI of WHO for 2008, 2009, and 2010. It is
noteworthy that the estimates of AirQ for different air pol-
lutants should not be summed as it leads to overestimation
(double counting) of somemortality/morbidity cases [24].
Input adjustments
HIA by AirQ needs concentration data of pollutants in
μg/m3 units. Thus, if the measurements of the monitors
were reported in parts-per-million (ppm) or parts-per-
billion (ppb) units, it would be necessary first to transform
ppm or ppb to μg/m3 units. In this procedure, there would
be some adjustments for pressure and temperature.
Hence, the following equation was used to transform ppm
to μg/m3 units [25]:
C
μg
m3
 
¼ C ppmð Þ MW
V
 1000 ð5Þ
Where C denotes the concentration of gaseous compos-
ition, MW denotes the relative molecular mass of gaseous
composition, and V denotes the volume of one mole of
pure gas at standard temperature and pressure (STP—0°C
and 1 atmosphere).
We also made corrections for non-standard tempera-
tures and pressures using Ideal Gas Equation:
P1V 1
T 1
¼ P2V 2
T 2
ð6Þ
Where P1, V1, and T1 are the initial pressure, volume
and absolute temperature and P2,V2, and T2 are the final
pressure, volume and absolute temperature.
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Results of part I
Figure 2 shows descriptive statistics of air quality in
Shiraz in 2008 to 2010. The maximum daily and annual
mean PM10 concentrations in 2009 were 1024.4 and
111.3 μg/m3, respectively. In 2008, the annual mean
concentration of SO2 was 674.9 μg/m
3, which is much
higher than daily means in 2009 and 2010. In addition,
the maximum annual mean concentration of NO2 con-
centration was in 2010, which was 90.0 μg/m3.
In Table 1, calculated RR and BI of the part I with
95% confidence interval (CI) in 10 μg increase of daily
mean of PM10, SO2, and NO2 pollutants have been tab-
ulated in relation with excess hospitalization cases due
to cardiovascular diseases, respiratory diseases, respira-
tory diseases in elderly group, and COPDs. As can be
seen in Table 1, no BI has been reported for respiratory
diseases in elderly group so that calculation of excess
cases due to short-term exposure to SO2 and NO2 pol-
lutants have been calculated considering RR of WHO &
BI of part I; and RR & BI of part I. According to the re-
sults of part I, association of PM10 and hospitalizations
due to cardiovascular diseases was not significant
(p > 0.05). However, there was a significant relationship
between PM10 and hospitalizations due to respiratory
diseases (p = 0.048). In addition, according to the find-
ings of part I, there was significant association between
SO2 and NO2 pollutants and hospitalizations due to
respiratory diseases in elderly group and COPDs
(p < 0.001).Figure 2 Annual concentrations of air pollutants (μg/m3) in Shiraz, IraResults of part II
In Table 2, the numbers of excess hospitalization cases
due to cardiovascular and respiratory diseases as a re-
sult of short-term exposure to PM10 in 2008 to 2010
have been tabulated. As can be seen, the maximum
number of excess hospitalizations due to cardiovascu-
lar and respiratory diseases is related to RR of WHO
& BI of part I; and RR & BI of WHO, respectively.
According to the results of this table, the maximum num-
ber of excess hospitalizations due to cardiovascular and
respiratory diseases is because of short-term exposure to
PM10 in 2009.
In Table 3, the numbers of excess hospitalizations
due to respiratory diseases in elderly group and
COPDs because of short-term exposure to SO2 have
been calculated based on a combination of RR & BI of
WHO (default values). According to the results of this
table, the maximum numbers of hospitalizations due
to respiratory diseases are in elderly group and hospi-
talizations due to COPDs because of short-term
exposure to SO2 in 2008.
In Table 4, the number of excess hospitalizations
due to respiratory diseases in elderly group and
COPDs as a result of short-term exposure to NO2
have been calculated based on a combination of RR &
BI of WHO (default values). According to the results
of this table, the maximum numbers of hospitaliza-
tions due to respiratory diseases are in elderly group
and hospitalizations due to COPDs because of short-
term exposure to NO2 in 2010.n from 2008 to 2010.
Table 1 Relative risks with 95% confidence interval for each 10 μg/m3 increase in daily mean concentrations of PM10,
SO2, and NO2
Health end point
PM10 SO2 NO2 BI per 100000
WHO RR Part I RR WHO RR Part I RR WHO RR Part I RR WHO Part I
(95% CI) (95% CI) (95% CI) (95% CI) (95% CI) (95% CI)
Hospital admissions
due to CDs
1.009 1.002 -* - - - 436 1447
(1.006 to 1.013) (1.0001 to 1.0040)
Hospital admissions
due to RDs
1.0080 1.0049 - - - - 1260 849
(1.0048 to 1.0112) (1.0004 to 1.0110)
Hospital admissions
due to RDsE**
- - 1.004 1.054 1.0038 1.028 -*** 61
(1.001 to 1.009) (1.005 to 1.120) (1.0000 to 1.0120) (1.011 to 1.045)
Hospital admissions
due to COPDs
-**** - 1.0044 1.095 1.0038 1.036 101.4 92
(1.0000 to 1.0110) (1.070 to 1.110) (1.0004 to 1.0094) (1.021 to 1.051)
Abbreviations: BI baseline incidence, CDs cardiovascular diseases, CI confidence interval, COPDs chronic obstructive pulmonary diseases, NO2 nitrogen dioxide,
PM10 particulate matter with aerodynamic diameter less than 10 μm, RDs respiratory diseases, RDsE respiratory diseases in elderly group (people older than 65
years-old), RR relative risk, SO2 sulfur dioxide, WHO World Health Organization.
*There are no RRs for cardiovascular and respiratory diseases due to short-term exposure to SO2 and NO2 in AirQ software so that they were not calculated in part
I of the study.
** Based on classification of AirQ.
***The BI has not been presented in AirQ for respiratory diseases in elderly group.
**** There is no RR for COPDs due to short-term exposure to PM10 in AirQ so that it is not calculated in part I of the study.
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In this research, the authors tried to quantify effects of
short-term exposure to specific air pollutants—PM10,
SO2, and NO2—on some health consequences including
cardiovascular and respiratory diseases, such as COPDs,
using AirQ model in different scenarios. In other words,
we tried to estimate excess hospitalization cases due to
cardiovascular diseases, respiratory diseases, respiratory
diseases in elderly group, and COPDs due to short-term
exposure to air pollutants. Noteworthy, estimation of
number of excess hospitalizations due to respiratory
diseases as a result of short-term exposure to SO2 and
NO2 are categorized in three age-groups including < 15,
15–65, and ≥ 65 years-old. Notwithstanding, in this
study—part I—categorization of patients was in two
groups (< 65 and ≥ 65 years-old). Thus, calculation of
RR and BI for ≤ 15 and 15–65 years-old age-groups was
impossible so that calculation of RR, BI, and number of
excess hospitalizations due to respiratory diseases was
done for ≥ 65 years-old age-group.Table 2 Number of excess hospitalizations due to cardiovascu
exposure to PM10 in 2008 to 2010
Year Health end point
WHO RR &
2008 Hospital admissions due to cardiovascular diseases 419
Hospital admissions due to respiratory diseases 1084
2009 Hospital admissions due to cardiovascular diseases 449
Hospital admissions due to respiratory diseases 1163
2010 Hospital admissions due to cardiovascular diseases 388
Hospital admissions due to respiratory diseases 1004
Abbreviations: WHO World Health Organization, RR relative risk, BI baseline incidencAs illustrated in Figure 2, the annual mean concentra-
tion of PM10 in 2008 to 2010 has been 102.5, 111.3, and
92.1 μg/m3, respectively. Likewise, analyses of PM10 con-
centrations in 2008 to 2010 revealed occurrence of MED
events, especially in 2009, which can affect results of Part
I. With this in mind, indeed, AirQ software has been de-
veloped based on RRs of exposure to traffic-related air
pollutants so that RRs of this software may not necessarily
be applicable for HIA of MED events [24]. Meanwhile, the
annual mean concentration of SO2 in 2008 to 2010 has
been 674.8, 209.4, and 32.7 μg/m3, respectively, which
shows a decreasing slope. This may be due to the decrease
of sulfur in the fuel and/or increase of vehicles that use
compressed natural gas (CNG) for gas up—albeit this
point has been confirmed by F-DOE that those vehicles
that use gasoline for gas up are responsible for SO2 pollu-
tion in Shiraz. In addition, the annual mean concentration
of NO2 during the mentioned period has been 55.0, 55.8,
and 90.0 μg/m3, respectively, which evidently is increased
and supports the notion of increase in use of CNG insteadlar and respiratory diseases as a result of short-term
Number of excess cases
BI WHO RR & Part I BI Part I RR & BI Part I RR & WHO BI
1389 328 99
731 460 682
1489 353 106
783 494 733
1287 302 91
677 424 630
e.
Table 3 Number of excess hospitalizations due to respiratory diseases as a result of short-term exposure to SO2 in
2008 to 2010
Year Health end point
Number of excess cases
WHO RR & BI WHO RR & Part I BI Part I RR & BI Part I RR & WHO BI
2008
Hospital admissions due to RDsE - 110 520 -
Hospital admissions due to COPDs 198 180 900 992
2009
Hospital admissions due to RDsE - 60 410 -
Hospital admissions due to COPDs 108 98 776 855
2010
Hospital admissions due to RDsE - 7 137 -
Hospital admissions due to COPDs 13 12 208 229
Abbreviations: WHO World Health Organization, RR relative risk, BI baseline incidence, RDsE respiratory diseases in elderly group (people older than 65 years-old),
COPDs chronic obstructive pulmonary diseases.
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gen oxides.
As shown in Table 1, the calculated BI per 100,000
people in part I of the study due to respiratory diseases, is
25% less than BI of WHO whilst this measure for cardio-
vascular diseases is 4.9 fold of WHO's BI. While these
may be true, it is obvious that Shiraz is medical hub in
Southwest of Iran and it hosts many patients from outside
of the city. Since there were no adequate and accurate ad-
dresses for patients by MRDs of hospitals, all admissions
were entered to the calculation of BI, which this may be
the reason for obtaining greater BI for part I rather than
BI of WHO.
There is no BI value for hospitalizations due to re-
spiratory diseases in ≥ 65 years-old age-group as a result
of short-term exposure to SO2 and NO2 in the AirQ
software so that the number of excess hospitalization
cases were calculated by a combination of WHO's RR,
part I's RR, and BI of part I of the study.
HIA of air pollution in Shiraz city using AirQ software
revealed that the share of admissions for cardiovascular
diseases as a result of exposure to PM10 during 2008 to
2010 and considering to RR & BI of WHO are 2.3%,
2.1%, and 1.5% out of all shares of admissions due to
cardiovascular diseases, respectively. Meanwhile, the share
of admissions for cardiovascular diseases as a result ofTable 4 Number of excess hospitalizations due to respiratory
2008 to 2010
Year Health end point
WHO RR & BI
2008 Hospital admissions due to RDsE -
Hospital admissions due to COPDs 21
2009 Hospital admissions due to RDsE -
Hospital admissions due to COPDs 22
2010 Hospital admissions due to RDsE -
Hospital admissions due to COPDs 39
Abbreviations: WHO World Health Organization, RR relative risk, BI baseline incidenc
COPDs chronic obstructive pulmonary diseases.exposure to PM10 during 2008 to 2010 and considering to
RR & BI of part I are 1.8%, 1.6%, and 1.2% out of
all shares of admissions due to cardiovascular diseases,
respectively, which are lower than estimates by using
WHO's RR & BI. Furthermore, results revealed that the
share of admissions for respiratory diseases as a result of
exposure to PM10 during 2008 to 2010 and considering to
RR & BI of WHO are 19.0%, 15.6%, and 10.8% out of
all shares of admissions due to respiratory diseases, re-
spectively. Also, the shares of admissions for respiratory
diseases as a result of exposure to PM10 during 2008 to
2010 and considering to RR & BI of part I are 8.1%,
6.6%, and 4.6% out of all shares of admissions due to
respiratory diseases, respectively, and are lower than esti-
mates by using WHO's RR and BI.
As tabulated in Table 2, in line with estimates, the
maximum number of excess hospitalizations due to car-
diovascular and respiratory diseases attributable to PM10
exposure have been occurred in 2009, which is due to
high concentrations of PM10 during most times of the
year. Indeed, it is important to note that albeit calculated
RRs for increase in 10 μg/m3 of PM10 are small for indi-
viduals, there would be extensive impacts in general
population when they have exposure with PM10.
The shares of admissions due to respiratory diseases in
elderly group as a result of exposure to SO2 during 2008diseases as a result of short-term exposure to NO2 in
Number of excess cases
WHO RR & Part I BI Part I RR & BI Part I RR & WHO BI
13 57 -
19 160 177
13 89 -
20 166 183
23 145 -
35 265 292
e, RDsE respiratory diseases in elderly group (people older than 65 years-old),
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6.4%, 2.7%, and 0.3% out of all shares of admissions
due to respiratory diseases in elderly group, respectively.
Also, the shares of admissions due to respiratory diseases
in elderly group as a result of exposure to SO2 during
2008 to 2010 and considering to RR & BI of part I are
30.3%, 18.3%, and 4.9% out of all shares of admissions
due to respiratory diseases in elderly group, respectively.
The shares of admissions for COPDs as a result of
exposure to SO2 during 2008 to 2010 and considering to
RR and BI of WHO are 12.4%, 5.3%, and 0.5% out of
all shares of admissions due to COPDs, respectively.
Also, the share of admissions for COPDs as a result of
exposure to SO2 during 2008 to 2010 and considering to
RR & BI of part I are 56.2%, 37.8%, and 8.3% out of
all shares of admissions due to COPDs, respectively. In
fact, various factors, such as smoking, occupational expo-
sures, inappropriate diet, indoor air pollution, exposure to
NO2 and particulate matters can influence incidence of
COPDs and RDs, especially in elderly people, but expos-
ure to air pollutants can exacerbate these diseases as pre-
disposing factors [26-34].
The share of admissions due to respiratory diseases in
elderly group as a result of exposure to NO2 during
2008 to 2010 and considering to RR of WHO & BI of
part I are 0.8%, 0.6%, and 0.8% out of all shares of
admissions due to respiratory diseases in elderly group,
respectively. Also, the shares of admissions due to re-
spiratory diseases in elderly group as a result of exposure
to NO2 during 2008 to 2010 and considering to RR & BI
of part I are 3.3%, 4.0%, and 5.2% out of all shares of
admissions due to respiratory diseases in elderly group,
respectively.
The shares of admissions due to COPDs as a result of
exposure to NO2 during 2008 to 2010 and considering
to RR of WHO and BI of part I are 1.3%, 1.1%, and
1.6% out of all shares of admissions due to COPDs, re-
spectively. Also, the shares of admissions due to COPDs
as a result of exposure to NO2 during 2008 to 2010 and
considering to RR & BI of part I are 10.0%, 8.1%, and
10.6% out of all shares of admissions due to COPDs,
respectively.
As tabulated in Tables 1, 2, 3, and 4, combination of
RRs and BIs of WHO and part I give different results.
There is no doubt, by all means, that the number of
hospitalizations would decrease by abatement of air
pollutants concentrations, even in using combinations of
all RRs and BIs.
Many researchers, worldwide, have used the AirQ
model. The majority of them, however, have focused on
short-term effects of air pollutants on mortality due to
cardiovascular and respiratory diseases [5,23,35-37]. For
instance, Naddafi et al. (2012) have estimated that short-
term exposure to air pollutants including PM10, SO2,NO2, and O3 in Tehran caused 2194, 1458, 1050, and
819 excess total mortality cases, respectively [5].
Conclusions
This study was the first attempt to assess health impacts
of air pollution in Shiraz, Iran. Although the results of
this study are in line with results of other researches
around the world, since the geographic, demographic,
and climate characteristics are different, there is still
high need to further studies to specify local RRs and BIs.
As mentioned above, air quality affects daily hospital
admissions dramatically. Accordingly, cost-effective mea-
sures and management schemes should be considered to
abate air pollution concentrations and/or reduce expos-
ure of general population to air pollutants.
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